Clearance Summary
OVUSIGN LH/CONCEPTION PLUS/OVUDATE LH ONE-STEP received FDA 510(k) clearance under submission number K930185, sponsored by Princeton Biomedix. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1993-03-04.
- Submission: K930185
- Applicant / Sponsor: Princeton Biomedix
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1485
- Decision date: 1993-03-04
Classification & Regulation
This clearance is catalogued under FDA product code CEP and 21 CFR 862.1485, within the Clinical Chemistry review panel as a Class I device.